Titlebook: Cell Biology and Translational Medicine, Volume 8; Stem Cells in Regene Kursad Turksen Book 2020 The Editor(s) (if applicable) and The Auth

只看該作者 · 發(fā)表于 2025-3-29 05:50:35

G. Contopoulos,N. Voglis,C. Efthymiopoulos stem cell (MSC) as a suitable stem cell source for cell-based therapy has been shown to be safe and effective in multiple clinical trial studies (CTSs) of several diseases. Despite the advantages, MSC needs more investigation to enhance its therapeutic application. The CRISPR/Cas system is a novel

只看該作者 · 發(fā)表于 2025-3-29 07:40:51

只看該作者 · 發(fā)表于 2025-3-29 15:02:18

只看該作者 · 發(fā)表于 2025-3-29 18:58:20

只看該作者 · 發(fā)表于 2025-3-29 21:17:33

Yu. G. Shkuratov,A. V. Ovcharenkogations in stem cells revealed that mesenchymal stem cells can successfully differentiate into other type of cells like adipocytes, hepatocytes, osteocytes, neurocytes and chondrocytes. In addition, these cells can also differentiate into insulin-producing beta cells. Insulin is a crucial hormone fo

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 05:03
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved